CRP and cardiovascular disorder: These results together with the results by Torzewski [11] add a cautionary note to the idea of targeting CRP as therapeutic intervention against progressive cardiovascular disease and point out that CRP might actually serve a physiological and primarily nonharmful function, as first proposed in 2004 [31].